Genmab

2,062.00 DKK

+1.93 %

Less than 1K followers

GMAB

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview

Financials & Estimates

Investor consensus

Compare

+1.93 %

+10.59 %

+18.17 %

+43.34 %

+38.16 %

+34.64 %

-37.08 %

-12.74 %

+5,946.92 %

Genmab is a pharmaceutical company. The company specializes in the research and development of antibodies, which are mainly used in the treatment of cancer patients with lymphatic leukemia and solid tumors. Research and development are based on the company's own developed technology platform and operations are held on a global level. Genmab was founded in 1999 and is headquartered in Copenhagen, Denmark.

Market cap

132.46B DKK

Turnover

193.21M DKK

Revenue

21.53B

EBIT %

31.14 %

P/E

16.87

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

5.2

2026

Annual report '25

19.3

2026

General meeting '26

7.5

2026

Interim report Q1'26

All

Research

Press releases

ShowingAll content types

Press releaseyesterday

Genmab Announces Closing of Private Offering of Senior Secured Notes and Senior Unsecured Notes

Genmab

Regulatory press release12/1/2025, 9:24 PM

Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons

Genmab

Press release11/24/2025, 12:00 PM

Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami

Genmab

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Create account

Regulatory press release11/20/2025, 8:02 PM

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Genmab

Regulatory press release11/19/2025, 5:55 PM

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Genmab

Video11/19/2025, 8:15 AM by

Rasmus Køjborg, Philip Coombes

HCA Morgenbørs 19/11 - Afventende markeder forud for Nvidia-regnskabet og fokus på NKT, Bioporto og Genmab

I dagens Morgenbørs ser vi ind i fortsat røde aktiemarkeder. Alle afventer Nvidia-regnskabet for Q3 2025 i aften efter markedets lukning i USA. Herhjemme fokus på bl.a. NKT, Bioporto og Genmab.

NKT Genmab BioPorto Føroya Banki

Press release11/18/2025, 9:01 PM

Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility

Genmab

Regulatory press release11/18/2025, 7:58 PM

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab

Regulatory press release11/18/2025, 4:30 PM

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Genmab

HCA Morgenbørs 17/11 - Afventende futures og fokus på FLSmidth og GreenMobility

Video11/17/2025, 8:16 AM by

Michael Friis, Rasmus Køjborg

HCA Morgenbørs 17/11 - Afventende futures og fokus på FLSmidth og GreenMobility

I dagens Morgenbørs ser vi ind i blandede futures globalt og en afventende stemning forud for Nvidias regnskab og jobtal senere på ugen. Herhjemme er der fokus på GreenMobility og FLS.

FLSmidth & Co.SP Group NKT Lollands Bank BioPorto Nilfisk Holding Gabriel Holding Scandinavian Medical Solutions Danske Andelskassers Bank Møns Bank GreenMobility Ascelia Pharma Bavarian Nordic Genmab Tryg

Press release11/10/2025, 3:51 PM

Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes

Genmab

Press release11/10/2025, 12:12 PM

Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility

Genmab

HCA Morgenbørs 10/11 - Positive futures på mulig genåbning i USA og fokus på Novo Nordisk

Video11/10/2025, 8:09 AM by

Michael Friis, Rasmus Køjborg

HCA Morgenbørs 10/11 - Positive futures på mulig genåbning i USA og fokus på Novo Nordisk

I dagens Morgenbørs ser vi ind i et stort hop op i de amerikanske futures på en mulig amerikansk genåbning. Herhjemme er der blandt andet fokus på Novo Nordisk og Genmab.

Novo Nordisk ChemoMetec Genmab NTG Nordic Transport Group H+H International Wirtek FLSmidth & Co.Lundbeck Schouw & Co Matas Royal Unibrew ALK-Abelló Zealand Pharma Bavarian Nordic

HCA Morgenbørs 07/11 - Positive futures og fokus på Novo Nordisk, Bavarian, Gubra og Genmab

Video11/7/2025, 8:13 AM by

Michael Friis, Rasmus Køjborg

HCA Morgenbørs 07/11 - Positive futures og fokus på Novo Nordisk, Bavarian, Gubra og Genmab

I dagens Morgenbørs ser vi ind i positive futures efter gårsdagens nedtur. Herhjemme er der fokus på Novo, Bavarian, Gubra, Genmab og andre regnskabsaktuelle selskaber.

Novo Nordisk Bavarian Nordic Zealand Pharma Genmab Gubra Novonesis Torm DFDS Vestas Wind Systems DSV A.P. Møller - Mærsk

Regulatory press release11/6/2025, 4:02 PM

Genmab Announces Financial Results for the Nine Months of 2025

Genmab

Press release11/5/2025, 5:58 PM

Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London

Genmab

Press release11/3/2025, 2:05 PM

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

Genmab

HCA Morgenbørs 03/11 - Svagt positive markeder drevet af yderligere deeskalering mellem USA og Kina

Video11/3/2025, 8:20 AM by

Michael Friis, Rasmus Køjborg

HCA Morgenbørs 03/11 - Svagt positive markeder drevet af yderligere deeskalering mellem USA og Kina

I dagens Morgenbørs ser vi ind i svagt positive markeder, drevet af yderligere deeskalering mellem USA og Kina. Herhjemme er der fokus på FLS, H+H og optakten til regnskabsstormen.

Novo Nordisk Genmab H+H International FLSmidth & Co.A.P. Møller - Mærsk GN Store Nord DFDS Torm DSV Asetek Føroya Banki Vestas Wind Systems Ørsted Coloplast Zealand Pharma Gubra SKAKO North Media Grønlandsbanken

Press release10/21/2025, 12:12 PM

Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.

Genmab

HCA Morgenbørs 21/10 - vi ser ind i et aktiemarked, hvor der dagligt sættes nye rekorder på globalt plan

Video10/21/2025, 7:20 AM by

Philip Coombes

HCA Morgenbørs 21/10 - vi ser ind i et aktiemarked, hvor der dagligt sættes nye rekorder på globalt plan

I dagens Morgenbørs ser vi ind i et aktiemarked, hvor der dagligt sættes nye rekorder på globalt plan. Herhjemme så småt fokus på Q3-regnskaberne der begynder at løbe ind i både Danmark og Norden bl.a. Embla Medical, Assa Abloy, Getinge, Husqvarna, Nordnet mv.

Embla Medical FLSmidth & Co.Vestas Wind Systems Genmab Novo Nordisk Ørsted